Form 4: Cardio Diagnostics Holdings Officer Acquires Shares in Recent Transaction

Meeshanthini Dogan, Chief Technology Officer of Cardio Diagnostics Holdings, Inc., reports the acquisition of 68,965 shares of common stock at $0.29 per share.

Summary

• On September 6, 2024, Meeshanthini Dogan, the Chief Technology Officer of Cardio Diagnostics Holdings, Inc. (CDIO), acquired 68,965 shares of common stock at a price of $0.29 per share.
• The transaction increased Dogan's direct ownership to 197,310 shares.
• The shares are held in an account with his spouse, the issuer's Chief Executive Officer, as joint tenants with rights of survivorship.
• The reporting person's direct ownership is 128,345 shares of common stock held individually and 68,965 shares of common stock held jointly with his spouse, the issuer's Chief Executive Officer.

Sentiment

Score: 6

Explanation: Neutral sentiment. The document simply reports a transaction. The purchase by an officer is mildly positive, but not significantly so without additional context.

Positives

• The acquisition of shares by a company officer can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored as they can provide insights into a company's performance and future expectations. This transaction is a routine disclosure required by the SEC.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment.

Key Dates